Chemosensitization Effects of XIAP Downregulation in K562 Leukemia Cells
- 1 February 2006
- journal article
- Published by Taylor & Francis Ltd in Journal of Chemotherapy
- Vol. 18 (1), 98-102
- https://doi.org/10.1179/joc.2006.18.1.98
Abstract
The effect of downregulation of the expression of the antiapoptotic protein XIAP with antisense oligonucleotides was evaluated in the K562 chronic myeloid leukemia (CML) cell line. This was carried out by studying the effects of downregulation of XIAP expression on cellular viability, cellular apoptosis and on the response to two chemotherapeutical drugs, etoposide and doxorubicin. We document that downregulation of XIAP expression decreased cellular viability, increased cellular apoptosis and enhanced the effects of doxorubicin.Keywords
This publication has 12 references indexed in Scilit:
- Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms: INTERMEDIACY OF H2O2- AND p53-DEPENDENT PATHWAYSOnline Journal of Public Health Informatics, 2004
- Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cellsCancer Gene Therapy, 2004
- CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammalsGenes & Development, 2003
- Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug‐resistant TCC in vitroInternational Journal of Cancer, 2002
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent MechanismJournal of Biological Chemistry, 2002
- Limited synergistic effect of antisense oligonucleotides against bcr-abl and transferrin receptor mRNA in leukemic cells in cultureCancer Letters, 2000
- p53-Independent Down-Regulation of Mdm2 in Human Cancer Cells Treated with AdriamycinMolecular Cell Biology Research Communications, 2000